Philadelphia, April 30, 2025 – Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive ...

Roflumilast has the potential to be used in a large segment of the COPD population. COPD is one of the leading causes of morbidity and mortality, occurring in approximately 10% of the population in ...

A Vietnamese doctor and his colleague check X-rays of a drug-resistant tuberculosis patient at the National Lung Hospital in Hanoi - Copyright AFP Brendan SMIALOWSKI ...

Chronic inflammation is the underlying mechanism that causes structural changes and the resulting symptoms of COPD. Variations in the airways and lung parenchyma cause physiologic changes that result ...